Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
97.75B | 80.29B | 79.91B | 74.60B | 69.00B | 61.64B | Gross Profit |
24.77B | 20.35B | 18.13B | 17.05B | 14.58B | 15.33B | EBIT |
15.80B | 11.63B | 9.48B | 8.66B | 7.02B | 7.95B | EBITDA |
16.35B | 12.18B | 9.90B | 9.00B | 7.28B | 8.13B | Net Income Common Stockholders |
10.08B | 7.52B | 6.15B | 5.43B | 4.51B | 5.07B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.82B | 16.24B | 26.55B | 27.72B | 31.85B | 19.66B | Total Assets |
54.69B | 168.95B | 135.87B | 114.32B | 104.88B | 80.49B | Total Debt |
23.02B | 86.63B | 62.35B | 44.63B | 37.45B | 22.69B | Net Debt |
8.20B | 70.38B | 35.80B | 16.90B | 5.60B | 3.03B | Total Liabilities |
29.66B | 102.08B | 74.90B | 58.62B | 53.74B | 33.30B | Stockholders Equity |
25.03B | 66.87B | 60.97B | 55.70B | 51.14B | 47.20B |
Cash Flow | Free Cash Flow | ||||
0.00 | -32.80B | -17.87B | -10.36B | -798.48M | -12.19B | Operating Cash Flow |
0.00 | -32.21B | -12.86B | -9.37B | -9.06M | -10.87B | Investing Cash Flow |
0.00 | -603.22M | -4.82B | -1.06B | -799.88M | -1.29B | Financing Cash Flow |
0.00 | 22.51B | 16.71B | 6.41B | 12.99B | 7.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥3.19T | 9.57 | 12.68% | 2.70% | 2.93% | -8.11% | |
76 Outperform | ¥65.65B | 7.04 | 4.35% | 22.43% | 52.18% | ||
73 Outperform | $3.78T | 15.29 | 7.82% | 2.16% | 0.83% | -6.10% | |
69 Neutral | $2.11T | 9.60 | 11.53% | 3.89% | 30.62% | 8.49% | |
69 Neutral | $2.53T | 13.16 | 8.93% | 1.32% | 5.85% | 3.72% | |
69 Neutral | ¥527.66B | 7.69 | 12.90% | 3.55% | 26.88% | 75.98% | |
60 Neutral | $2.76B | 10.33 | 0.49% | 8507.90% | 5.95% | -17.56% |